Changing from WHO-GMP to EU-GMP midway through design reopens the URS, validation master plan, DQ and drafted IQ/OQ protocols, and for sterile products the Annex 1 CCS. The market is one of five scoping questions, with the process, grades and room list, existing assets and the division needed first.
Precision in Practice: 3D Design in Pharmaceutical Projects. In pharmaceutical projects, 3D design is more than visualization — it is a foundation of compliance. In GMP-regulated environments, design decisions directly affect safety,…
In pharmaceutical facilities, contamination control is not defined by room classification alone — it is defined by how flows interact. Even a facility that meets cleanroom classification requirements can face GMP risks if critical flows…
A cleanroom can meet its classification on paper, yet fail GMP expectations if HVAC performance is unstable or poorly aligned with operational reality. Cleanroom performance is often discussed in terms of ISO classes or GMP grades.
In pharmaceutical facility design, if the HVAC system is the "lungs," then the Zoning and Pressure Cascade strategy is the "immune system." It creates invisible but effective barriers that prevent microbial ingress and strictly control…
Cleanroom surfaces look like a finishing trade and behave like a performance system. Wall, floor and ceiling finishes decide whether a room can be cleaned to its classification, how long it survives a sporicidal regime, and how much particulate it sheds back into the air it was built to keep clean.